INTERNATIONAL JOURNAL OF CLINICAL PRACTICE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2156913, encodeId=3e222156913a4, content=请教一下，为什么没有找到可以查看“稿件状态”的地方，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sat Sep 09 21:05:12 CST 2023, time=2023-09-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164718, encodeId=a5d32164e189e, content=请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Oct 24 22:21:17 CST 2023, time=2023-10-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1232833, encodeId=722b1232833f7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：急危重症;nomogram 经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab375719631, createdName=ms4000000507508187, createdTime=Sat Jul 16 18:43:46 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232842, encodeId=e9e6123284247, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Nomogram;急危重症 经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eria5doTVBMeibwXOF6MWQ6KlPOQL02o2Hjjtvibzym1RibMT89U1T7J0icJ8r1fmfpR5FuTrY7CP9QdUA/132, createdBy=73175216373, createdName=xy3yyqj, createdTime=Sat Jul 16 19:14:43 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156969, encodeId=7c98215696924, content=需要每位作者的邮箱都确认提交吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sun Sep 10 09:15:23 CST 2023, time=2023-09-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113780, encodeId=8b372113e8004, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：综合医学期刊 经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb148239357, createdName=ms8000000165155350, createdTime=Thu Feb 09 11:58:09 CST 2023, time=2023-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229512, encodeId=316f1229512ee, content=请问一下，投稿一个月还没送审，这个速度算慢了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7518221281, createdName=ms8000001495527271, createdTime=Wed Jun 29 18:11:25 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095175, encodeId=503920951e5da, content=请问一下，authorship confirmation 需要回复什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f218186011, createdName=ms2000000414087452, createdTime=Fri Oct 21 14:36:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089447, encodeId=896b208944e8f, content=投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 21 03:01:15 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184031, encodeId=ef4e11840315b, content=请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96ea2074338, createdName=1851f0cc81m, createdTime=Thu Jan 13 21:17:52 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2023-09-09 ms6000001587552606 来自江苏省

请教一下，为什么没有找到可以查看“稿件状态”的地方，

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156913, encodeId=3e222156913a4, content=请教一下，为什么没有找到可以查看“稿件状态”的地方，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sat Sep 09 21:05:12 CST 2023, time=2023-09-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164718, encodeId=a5d32164e189e, content=请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Oct 24 22:21:17 CST 2023, time=2023-10-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1232833, encodeId=722b1232833f7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：急危重症;nomogram 经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab375719631, createdName=ms4000000507508187, createdTime=Sat Jul 16 18:43:46 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232842, encodeId=e9e6123284247, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Nomogram;急危重症 经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eria5doTVBMeibwXOF6MWQ6KlPOQL02o2Hjjtvibzym1RibMT89U1T7J0icJ8r1fmfpR5FuTrY7CP9QdUA/132, createdBy=73175216373, createdName=xy3yyqj, createdTime=Sat Jul 16 19:14:43 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156969, encodeId=7c98215696924, content=需要每位作者的邮箱都确认提交吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sun Sep 10 09:15:23 CST 2023, time=2023-09-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113780, encodeId=8b372113e8004, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：综合医学期刊 经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb148239357, createdName=ms8000000165155350, createdTime=Thu Feb 09 11:58:09 CST 2023, time=2023-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229512, encodeId=316f1229512ee, content=请问一下，投稿一个月还没送审，这个速度算慢了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7518221281, createdName=ms8000001495527271, createdTime=Wed Jun 29 18:11:25 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095175, encodeId=503920951e5da, content=请问一下，authorship confirmation 需要回复什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f218186011, createdName=ms2000000414087452, createdTime=Fri Oct 21 14:36:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089447, encodeId=896b208944e8f, content=投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 21 03:01:15 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184031, encodeId=ef4e11840315b, content=请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96ea2074338, createdName=1851f0cc81m, createdTime=Thu Jan 13 21:17:52 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2023-10-24 ms6000001587552606 来自江苏省

请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊

19 0

[GetPortalCommentsPageByObjectIdResponse(id=2156913, encodeId=3e222156913a4, content=请教一下，为什么没有找到可以查看“稿件状态”的地方，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sat Sep 09 21:05:12 CST 2023, time=2023-09-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164718, encodeId=a5d32164e189e, content=请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Oct 24 22:21:17 CST 2023, time=2023-10-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1232833, encodeId=722b1232833f7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：急危重症;nomogram 经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab375719631, createdName=ms4000000507508187, createdTime=Sat Jul 16 18:43:46 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232842, encodeId=e9e6123284247, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Nomogram;急危重症 经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eria5doTVBMeibwXOF6MWQ6KlPOQL02o2Hjjtvibzym1RibMT89U1T7J0icJ8r1fmfpR5FuTrY7CP9QdUA/132, createdBy=73175216373, createdName=xy3yyqj, createdTime=Sat Jul 16 19:14:43 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156969, encodeId=7c98215696924, content=需要每位作者的邮箱都确认提交吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sun Sep 10 09:15:23 CST 2023, time=2023-09-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113780, encodeId=8b372113e8004, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：综合医学期刊 经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb148239357, createdName=ms8000000165155350, createdTime=Thu Feb 09 11:58:09 CST 2023, time=2023-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229512, encodeId=316f1229512ee, content=请问一下，投稿一个月还没送审，这个速度算慢了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7518221281, createdName=ms8000001495527271, createdTime=Wed Jun 29 18:11:25 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095175, encodeId=503920951e5da, content=请问一下，authorship confirmation 需要回复什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f218186011, createdName=ms2000000414087452, createdTime=Fri Oct 21 14:36:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089447, encodeId=896b208944e8f, content=投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 21 03:01:15 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184031, encodeId=ef4e11840315b, content=请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96ea2074338, createdName=1851f0cc81m, createdTime=Thu Jan 13 21:17:52 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2022-07-16 ms4000000507508187

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：急危重症;nomogram
经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好

58 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156913, encodeId=3e222156913a4, content=请教一下，为什么没有找到可以查看“稿件状态”的地方，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sat Sep 09 21:05:12 CST 2023, time=2023-09-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164718, encodeId=a5d32164e189e, content=请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Oct 24 22:21:17 CST 2023, time=2023-10-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1232833, encodeId=722b1232833f7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：急危重症;nomogram 经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab375719631, createdName=ms4000000507508187, createdTime=Sat Jul 16 18:43:46 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232842, encodeId=e9e6123284247, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Nomogram;急危重症 经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eria5doTVBMeibwXOF6MWQ6KlPOQL02o2Hjjtvibzym1RibMT89U1T7J0icJ8r1fmfpR5FuTrY7CP9QdUA/132, createdBy=73175216373, createdName=xy3yyqj, createdTime=Sat Jul 16 19:14:43 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156969, encodeId=7c98215696924, content=需要每位作者的邮箱都确认提交吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sun Sep 10 09:15:23 CST 2023, time=2023-09-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113780, encodeId=8b372113e8004, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：综合医学期刊 经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb148239357, createdName=ms8000000165155350, createdTime=Thu Feb 09 11:58:09 CST 2023, time=2023-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229512, encodeId=316f1229512ee, content=请问一下，投稿一个月还没送审，这个速度算慢了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7518221281, createdName=ms8000001495527271, createdTime=Wed Jun 29 18:11:25 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095175, encodeId=503920951e5da, content=请问一下，authorship confirmation 需要回复什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f218186011, createdName=ms2000000414087452, createdTime=Fri Oct 21 14:36:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089447, encodeId=896b208944e8f, content=投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 21 03:01:15 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184031, encodeId=ef4e11840315b, content=请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96ea2074338, createdName=1851f0cc81m, createdTime=Thu Jan 13 21:17:52 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2022-07-16 xy3yyqj

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：Nomogram;急危重症
经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了

94 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156913, encodeId=3e222156913a4, content=请教一下，为什么没有找到可以查看“稿件状态”的地方，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sat Sep 09 21:05:12 CST 2023, time=2023-09-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164718, encodeId=a5d32164e189e, content=请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Oct 24 22:21:17 CST 2023, time=2023-10-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1232833, encodeId=722b1232833f7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：急危重症;nomogram 经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab375719631, createdName=ms4000000507508187, createdTime=Sat Jul 16 18:43:46 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232842, encodeId=e9e6123284247, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Nomogram;急危重症 经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eria5doTVBMeibwXOF6MWQ6KlPOQL02o2Hjjtvibzym1RibMT89U1T7J0icJ8r1fmfpR5FuTrY7CP9QdUA/132, createdBy=73175216373, createdName=xy3yyqj, createdTime=Sat Jul 16 19:14:43 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156969, encodeId=7c98215696924, content=需要每位作者的邮箱都确认提交吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sun Sep 10 09:15:23 CST 2023, time=2023-09-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113780, encodeId=8b372113e8004, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：综合医学期刊 经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb148239357, createdName=ms8000000165155350, createdTime=Thu Feb 09 11:58:09 CST 2023, time=2023-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229512, encodeId=316f1229512ee, content=请问一下，投稿一个月还没送审，这个速度算慢了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7518221281, createdName=ms8000001495527271, createdTime=Wed Jun 29 18:11:25 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095175, encodeId=503920951e5da, content=请问一下，authorship confirmation 需要回复什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f218186011, createdName=ms2000000414087452, createdTime=Fri Oct 21 14:36:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089447, encodeId=896b208944e8f, content=投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 21 03:01:15 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184031, encodeId=ef4e11840315b, content=请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96ea2074338, createdName=1851f0cc81m, createdTime=Thu Jan 13 21:17:52 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2023-09-10 ms6000001587552606 来自江苏省

需要每位作者的邮箱都确认提交吗

26 0

[GetPortalCommentsPageByObjectIdResponse(id=2156913, encodeId=3e222156913a4, content=请教一下，为什么没有找到可以查看“稿件状态”的地方，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sat Sep 09 21:05:12 CST 2023, time=2023-09-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164718, encodeId=a5d32164e189e, content=请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Oct 24 22:21:17 CST 2023, time=2023-10-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1232833, encodeId=722b1232833f7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：急危重症;nomogram 经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab375719631, createdName=ms4000000507508187, createdTime=Sat Jul 16 18:43:46 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232842, encodeId=e9e6123284247, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Nomogram;急危重症 经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eria5doTVBMeibwXOF6MWQ6KlPOQL02o2Hjjtvibzym1RibMT89U1T7J0icJ8r1fmfpR5FuTrY7CP9QdUA/132, createdBy=73175216373, createdName=xy3yyqj, createdTime=Sat Jul 16 19:14:43 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156969, encodeId=7c98215696924, content=需要每位作者的邮箱都确认提交吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sun Sep 10 09:15:23 CST 2023, time=2023-09-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113780, encodeId=8b372113e8004, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：综合医学期刊 经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb148239357, createdName=ms8000000165155350, createdTime=Thu Feb 09 11:58:09 CST 2023, time=2023-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229512, encodeId=316f1229512ee, content=请问一下，投稿一个月还没送审，这个速度算慢了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7518221281, createdName=ms8000001495527271, createdTime=Wed Jun 29 18:11:25 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095175, encodeId=503920951e5da, content=请问一下，authorship confirmation 需要回复什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f218186011, createdName=ms2000000414087452, createdTime=Fri Oct 21 14:36:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089447, encodeId=896b208944e8f, content=投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 21 03:01:15 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184031, encodeId=ef4e11840315b, content=请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96ea2074338, createdName=1851f0cc81m, createdTime=Thu Jan 13 21:17:52 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2023-02-09 ms8000000165155350 来自重庆

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：综合医学期刊
经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。

35 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156913, encodeId=3e222156913a4, content=请教一下，为什么没有找到可以查看“稿件状态”的地方，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sat Sep 09 21:05:12 CST 2023, time=2023-09-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164718, encodeId=a5d32164e189e, content=请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Oct 24 22:21:17 CST 2023, time=2023-10-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1232833, encodeId=722b1232833f7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：急危重症;nomogram 经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab375719631, createdName=ms4000000507508187, createdTime=Sat Jul 16 18:43:46 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232842, encodeId=e9e6123284247, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Nomogram;急危重症 经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eria5doTVBMeibwXOF6MWQ6KlPOQL02o2Hjjtvibzym1RibMT89U1T7J0icJ8r1fmfpR5FuTrY7CP9QdUA/132, createdBy=73175216373, createdName=xy3yyqj, createdTime=Sat Jul 16 19:14:43 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156969, encodeId=7c98215696924, content=需要每位作者的邮箱都确认提交吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sun Sep 10 09:15:23 CST 2023, time=2023-09-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113780, encodeId=8b372113e8004, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：综合医学期刊 经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb148239357, createdName=ms8000000165155350, createdTime=Thu Feb 09 11:58:09 CST 2023, time=2023-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229512, encodeId=316f1229512ee, content=请问一下，投稿一个月还没送审，这个速度算慢了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7518221281, createdName=ms8000001495527271, createdTime=Wed Jun 29 18:11:25 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095175, encodeId=503920951e5da, content=请问一下，authorship confirmation 需要回复什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f218186011, createdName=ms2000000414087452, createdTime=Fri Oct 21 14:36:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089447, encodeId=896b208944e8f, content=投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 21 03:01:15 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184031, encodeId=ef4e11840315b, content=请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96ea2074338, createdName=1851f0cc81m, createdTime=Thu Jan 13 21:17:52 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2022-06-29 ms8000001495527271

请问一下，投稿一个月还没送审，这个速度算慢了吗

54 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156913, encodeId=3e222156913a4, content=请教一下，为什么没有找到可以查看“稿件状态”的地方，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sat Sep 09 21:05:12 CST 2023, time=2023-09-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164718, encodeId=a5d32164e189e, content=请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Oct 24 22:21:17 CST 2023, time=2023-10-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1232833, encodeId=722b1232833f7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：急危重症;nomogram 经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab375719631, createdName=ms4000000507508187, createdTime=Sat Jul 16 18:43:46 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232842, encodeId=e9e6123284247, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Nomogram;急危重症 经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eria5doTVBMeibwXOF6MWQ6KlPOQL02o2Hjjtvibzym1RibMT89U1T7J0icJ8r1fmfpR5FuTrY7CP9QdUA/132, createdBy=73175216373, createdName=xy3yyqj, createdTime=Sat Jul 16 19:14:43 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156969, encodeId=7c98215696924, content=需要每位作者的邮箱都确认提交吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sun Sep 10 09:15:23 CST 2023, time=2023-09-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113780, encodeId=8b372113e8004, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：综合医学期刊 经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb148239357, createdName=ms8000000165155350, createdTime=Thu Feb 09 11:58:09 CST 2023, time=2023-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229512, encodeId=316f1229512ee, content=请问一下，投稿一个月还没送审，这个速度算慢了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7518221281, createdName=ms8000001495527271, createdTime=Wed Jun 29 18:11:25 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095175, encodeId=503920951e5da, content=请问一下，authorship confirmation 需要回复什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f218186011, createdName=ms2000000414087452, createdTime=Fri Oct 21 14:36:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089447, encodeId=896b208944e8f, content=投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 21 03:01:15 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184031, encodeId=ef4e11840315b, content=请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96ea2074338, createdName=1851f0cc81m, createdTime=Thu Jan 13 21:17:52 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2022-10-21 ms2000000414087452

请问一下，authorship confirmation 需要回复什么内容

49 0

[GetPortalCommentsPageByObjectIdResponse(id=2156913, encodeId=3e222156913a4, content=请教一下，为什么没有找到可以查看“稿件状态”的地方，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sat Sep 09 21:05:12 CST 2023, time=2023-09-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164718, encodeId=a5d32164e189e, content=请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Oct 24 22:21:17 CST 2023, time=2023-10-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1232833, encodeId=722b1232833f7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：急危重症;nomogram 经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab375719631, createdName=ms4000000507508187, createdTime=Sat Jul 16 18:43:46 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232842, encodeId=e9e6123284247, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Nomogram;急危重症 经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eria5doTVBMeibwXOF6MWQ6KlPOQL02o2Hjjtvibzym1RibMT89U1T7J0icJ8r1fmfpR5FuTrY7CP9QdUA/132, createdBy=73175216373, createdName=xy3yyqj, createdTime=Sat Jul 16 19:14:43 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156969, encodeId=7c98215696924, content=需要每位作者的邮箱都确认提交吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sun Sep 10 09:15:23 CST 2023, time=2023-09-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113780, encodeId=8b372113e8004, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：综合医学期刊 经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb148239357, createdName=ms8000000165155350, createdTime=Thu Feb 09 11:58:09 CST 2023, time=2023-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229512, encodeId=316f1229512ee, content=请问一下，投稿一个月还没送审，这个速度算慢了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7518221281, createdName=ms8000001495527271, createdTime=Wed Jun 29 18:11:25 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095175, encodeId=503920951e5da, content=请问一下，authorship confirmation 需要回复什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f218186011, createdName=ms2000000414087452, createdTime=Fri Oct 21 14:36:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089447, encodeId=896b208944e8f, content=投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 21 03:01:15 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184031, encodeId=ef4e11840315b, content=请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96ea2074338, createdName=1851f0cc81m, createdTime=Thu Jan 13 21:17:52 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2022-09-21 ms5000001759563327

投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156913, encodeId=3e222156913a4, content=请教一下，为什么没有找到可以查看“稿件状态”的地方，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sat Sep 09 21:05:12 CST 2023, time=2023-09-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164718, encodeId=a5d32164e189e, content=请问大家返修的时候，上传的是有修改痕迹的吗，使用修订模式还是直接标红就行啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Oct 24 22:21:17 CST 2023, time=2023-10-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1232833, encodeId=722b1232833f7, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：急危重症;nomogram 经验分享：总体印象还行，30天审稿，1个月修回，1周后录用，审稿速度挺快的，评审意见非常中肯，补了近1个月的实验和修改论文，编辑态度比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab375719631, createdName=ms4000000507508187, createdTime=Sat Jul 16 18:43:46 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232842, encodeId=e9e6123284247, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：Nomogram;急危重症 经验分享：比较中肯，审稿速度挺快的，1审30天，2审7天，中间返修自己花了近1个月，审稿人意见较多，但比较友好，努力补了实验后还是接收了，现在等着proof和版面费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eria5doTVBMeibwXOF6MWQ6KlPOQL02o2Hjjtvibzym1RibMT89U1T7J0icJ8r1fmfpR5FuTrY7CP9QdUA/132, createdBy=73175216373, createdName=xy3yyqj, createdTime=Sat Jul 16 19:14:43 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156969, encodeId=7c98215696924, content=需要每位作者的邮箱都确认提交吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Sun Sep 10 09:15:23 CST 2023, time=2023-09-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113780, encodeId=8b372113e8004, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：综合医学期刊 经验分享：该杂志已由威力旗下转到hindawi旗下，成为OA期刊，但是审稿周期似乎还延长了。去年12月份投了一篇meta，然后一天完成质量审核，进入AE INVITITED 阶段，到现在已经两个月了。中途催过两次，编辑部应该按模板进行回复，然后一直没有后续，官网公布审稿时间为66天，接受率为15%，送审前拒稿39%左右，准备撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb148239357, createdName=ms8000000165155350, createdTime=Thu Feb 09 11:58:09 CST 2023, time=2023-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229512, encodeId=316f1229512ee, content=请问一下，投稿一个月还没送审，这个速度算慢了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7518221281, createdName=ms8000001495527271, createdTime=Wed Jun 29 18:11:25 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095175, encodeId=503920951e5da, content=请问一下，authorship confirmation 需要回复什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f218186011, createdName=ms2000000414087452, createdTime=Fri Oct 21 14:36:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089447, encodeId=896b208944e8f, content=投了一个临床实践方面的文章编辑给了大修改了一周还没改完担心最后还是被拒过来求个平安顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 21 03:01:15 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184031, encodeId=ef4e11840315b, content=请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96ea2074338, createdName=1851f0cc81m, createdTime=Thu Jan 13 21:17:52 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2022-01-13 1851f0cc81m

请问这本杂志2022年开始更新发表文章了吗？12月接收的文章，一般什么时候出来啊？

54 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务